Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1956 3
1957 2
1958 2
1959 3
1961 4
1962 7
1963 11
1964 26
1965 17
1966 13
1967 15
1968 20
1969 30
1970 30
1971 16
1972 20
1973 22
1974 29
1975 25
1976 21
1977 29
1978 37
1979 39
1980 42
1981 35
1982 60
1983 55
1984 72
1985 91
1986 123
1987 117
1988 120
1989 150
1990 119
1991 118
1992 163
1993 142
1994 159
1995 168
1996 170
1997 179
1998 159
1999 191
2000 196
2001 179
2002 197
2003 191
2004 207
2005 217
2006 245
2007 219
2008 232
2009 302
2010 308
2011 341
2012 366
2013 364
2014 357
2015 406
2016 343
2017 369
2018 395
2019 405
2020 483
2021 505
2022 37
Text availability
Article attribute
Article type
Publication date

Search Results

8,878 results
Results by year
Filters applied: . Clear all
Page 1
Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week.
Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, Kutys B, Guo L, Cornelissen A, Mori M, Sato Y, Pescetelli I, Brivio M, Romero M, Guagliumi G, Virmani R, Finn AV. Kawakami R, et al. Among authors: mori m. J Am Coll Cardiol. 2021 Jan 26;77(3):314-325. doi: 10.1016/j.jacc.2020.11.031. J Am Coll Cardiol. 2021. PMID: 33478655 Free PMC article. Review.
Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans.
Dingler FA, Wang M, Mu A, Millington CL, Oberbeck N, Watcham S, Pontel LB, Kamimae-Lanning AN, Langevin F, Nadler C, Cordell RL, Monks PS, Yu R, Wilson NK, Hira A, Yoshida K, Mori M, Okamoto Y, Okuno Y, Muramatsu H, Shiraishi Y, Kobayashi M, Moriguchi T, Osumi T, Kato M, Miyano S, Ito E, Kojima S, Yabe H, Yabe M, Matsuo K, Ogawa S, Göttgens B, Hodskinson MRG, Takata M, Patel KJ. Dingler FA, et al. Among authors: mori m. Mol Cell. 2020 Dec 17;80(6):996-1012.e9. doi: 10.1016/j.molcel.2020.10.012. Epub 2020 Nov 3. Mol Cell. 2020. PMID: 33147438 Free PMC article.
Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H, Kubo M, Yamashita N, Yamamoto H, Kai M, Kajihara A, Yamada M, Kurata K, Kaneshiro K, Harada Y, Hayashi S, Shimazaki A, Mori H, Akiyoshi S, Oki E, Oda Y, Baba E, Mori M, Nakamura M. Kawaji H, et al. Among authors: mori m. Cancer Med. 2021 Jan;10(2):529-539. doi: 10.1002/cam4.3619. Epub 2020 Dec 4. Cancer Med. 2021. PMID: 33274848 Free PMC article.
Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
Pellegrini D, Kawakami R, Guagliumi G, Sakamoto A, Kawai K, Gianatti A, Nasr A, Kutys R, Guo L, Cornelissen A, Faggi L, Mori M, Sato Y, Pescetelli I, Brivio M, Romero M, Virmani R, Finn AV. Pellegrini D, et al. Among authors: mori m. Circulation. 2021 Mar 9;143(10):1031-1042. doi: 10.1161/CIRCULATIONAHA.120.051828. Epub 2021 Jan 22. Circulation. 2021. PMID: 33480806 Free article.
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study.
Ito K, Yamanaka T, Hayashi H, Hattori Y, Nishino K, Kobayashi H, Oya Y, Yokoyama T, Seto T, Azuma K, Fukui T, Kozuki T, Nakamura A, Tanaka K, Hirano K, Yokoi T, Daga H, Sakata S, Fujimoto D, Mori M, Maeno K, Aoki T, Tamura A, Miura S, Watanabe S, Akamatsu H, Hataji O, Suzuki K, Hontsu S, Azuma K, Bessho A, Kubo A, Okuno M, Nakagawa K, Yamamoto N. Ito K, et al. Among authors: mori m. Eur J Cancer. 2021 Mar;145:183-193. doi: 10.1016/j.ejca.2020.12.026. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33486442
Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial.
Oki E, Makiyama A, Miyamoto Y, Kotaka M, Kawanaka H, Miwa K, Kabashima A, Noguchi T, Yuge K, Kashiwada T, Ando K, Shimokawa M, Saeki H, Akagi Y, Baba H, Maehara Y, Mori M. Oki E, et al. Among authors: mori m. Cancer Med. 2021 Jan;10(2):454-461. doi: 10.1002/cam4.3618. Epub 2020 Nov 29. Cancer Med. 2021. PMID: 33249761 Free PMC article. Clinical Trial.
Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients With Clinical T4b Esophageal Cancer: Short-term Results.
Sugimura K, Miyata H, Tanaka K, Makino T, Takeno A, Shiraishi O, Motoori M, Yamasaki M, Kimura Y, Hirao M, Fujitani K, Yasuda T, Mori M, Eguchi H, Yano M, Doki Y. Sugimura K, et al. Among authors: mori m. Ann Surg. 2021 Dec 1;274(6):e465-e472. doi: 10.1097/SLA.0000000000004564. Ann Surg. 2021. PMID: 33065643 Clinical Trial.
25th anniversary of oral diseases.
Johnson NW, Warnakulasuriya S, Greenspan J, Mori M, Baum B. Johnson NW, et al. Among authors: mori m. Oral Dis. 2021 Sep;27(6):1339-1342. doi: 10.1111/odi.13709. Epub 2020 Nov 30. Oral Dis. 2021. PMID: 33140899 No abstract available.
Host Defense against Tumor.
Mori M. Mori M. JMA J. 2020 Jul 15;3(3):284-285. doi: 10.31662/jmaj.2020-0048. Epub 2020 Jul 13. JMA J. 2020. PMID: 33150265 Free PMC article. No abstract available.
Repurposing drugs for the management of COVID-19.
Cusinato J, Cau Y, Calvani AM, Mori M. Cusinato J, et al. Among authors: mori m. Expert Opin Ther Pat. 2021 Apr;31(4):295-307. doi: 10.1080/13543776.2021.1861248. Epub 2020 Dec 31. Expert Opin Ther Pat. 2021. PMID: 33283567 Review.
8,878 results